# Nasdaq:CLDX news releases

Nasdaq:CLDX press releases distributed through Connectively Wire to the journalists who cover the beat.

- **Releases in the last 90 days:** 271
- **Web page:** https://www.connectively.us/news-releases/nasdaqcldx
- **RSS:** https://www.connectively.us/news-releases/nasdaqcldx/rss.xml

### [Celldex Reports Results from Phase 2 Study of Barzolvolimab in Atopic Dermatitis](https://www.connectively.us/news-releases/celldex-reports-results-from-phase-2-study-of-barzolvolimab-in-atopic)

November 20, 2026 · Celldex Therapeutics · Nasdaq:CLDX

Study did not meet key efficacy measures or internal hurdle rate for continued development Systemic mast cell depletion observed, consistent with prior studies, as evidenced by significant reduction in serum tryptase Favorable safety and tolerability demonstrated, consistent…
